Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Long Coronavirus Disease (COVID) Cough: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study DOI Creative Commons
Xiaolong Xu, Ying Jie,

Taiping Tian

et al.

Engineering, Journal Year: 2024, Volume and Issue: 40, P. 61 - 69

Published: April 23, 2024

Lianhua Qingke tablets, a patented traditional Chinese medicine that has validated clinical efficacy for treating cough caused by severe acute respiratory syndrome coronavirus 2 infection, lack rigorous evidence-based research evaluating their effect on long disease (COVID) cough. A randomized, double-blind, placebo-controlled, multicenter study was conducted among patients with COVID from 19 hospitals and 23 community health centers in China. Patients were randomized 1:1 to receive either tablets or placebo orally 14 days (4 1.84 g, 3 times day). The primary endpoint indicator the disappearance of cough, remission also considered. Among 482 patients, 480 (full analysis set 480; per-protocol 470; safety 480) included analysis. According full analysis, time until significantly shorter trial group than control group, significant increase 14-day rate. Accordingly, group. change total symptom score greater day 7 14, consistent results indicated visual analog scale (VAS) evaluation test (CET) scores. No serious adverse events recorded during study. improved symptoms

Language: Английский

Risk assessment of CYP3A induction by ginsenosides’ metabolites from oral Panax notoginseng (Sanqi) extract DOI
Yang Deng, Jing Du, Xin He

et al.

Journal of Ethnopharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 119864 - 119864

Published: April 1, 2025

Language: Английский

Citations

0

Advancements in Plant-Derived sRNAs Therapeutics: Classification, Delivery Strategies, and Therapeutic Applications DOI Open Access
Quan Rao, Hua Hua, Junning Zhao

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(9), P. 4277 - 4277

Published: April 30, 2025

Plant-derived small RNAs (sRNAs) have garnered significant attention in nucleic acid therapeutics, driven by their distinctive cross-kingdom regulatory capabilities and extensive therapeutic promise. These sRNAs exhibit a wide range of pharmacological effects, including pulmonary protection, antiviral, anti-inflammatory, antitumor activities, underscoring substantial potential for clinical translation. A key advantage lies delivery, facilitated plant-specific nanovesicular carriers—such as plant exosomes, herbal decoctosomes, bencaosomes—which protect from gastrointestinal degradation enable precise, tissue-specific targeting. This review provides comprehensive analysis plant-derived sRNAs, detailing classification, gene-silencing mechanisms, nanovesicle-mediated delivery strategies. It further explores underlying molecular mechanisms major human diseases. Additionally, we critically evaluate current technical challenges propose future directions to advance the development precision therapeutics. work aims offer robust theoretical framework practical guidance advancement sRNA-based therapies.

Language: Английский

Citations

0

Integrated network pharmacology and experimental validation-based approach to reveal the underlying mechanisms and key material basis of Jinhua Qinggan granules against acute lung injury DOI

Yan Mi,

Yusheng Liang,

Yeshu Liu

et al.

Journal of Ethnopharmacology, Journal Year: 2024, Volume and Issue: 326, P. 117920 - 117920

Published: Feb. 17, 2024

Language: Английский

Citations

3

Cytokine Storm in COVID-19: Insight into Pathological Mechanisms and Therapeutic Benefits of Chinese Herbal Medicines DOI Creative Commons
Qingyuan Yu, Xian Zhou,

Rotina Kapini

et al.

Medicines, Journal Year: 2024, Volume and Issue: 11(7), P. 14 - 14

Published: July 18, 2024

Cytokine storm (CS) is the main driver of SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) in severe coronavirus disease-19 (COVID-19). The pathological mechanisms CS are quite complex and involve multiple critical molecular targets that turn self-limited mild COVID-19 into a life-threatening concern. At present, vaccines strongly recommended as safe effective treatments for preventing serious illness or death from COVID-19. However, treatment options still lacking people who at most risk hospitalized with disease. Chinese herbal medicines have been shown to improve clinical outcomes an adjunct therapy, particular development ARDS. This review illustrates detail pathogenesis CS-involved ARDS its associated key targets, cytokines signalling pathways. therapeutic were identified particularly relation turning points COVID-19, symptoms Preclinical studies reviewed effects together conventional therapies reducing addressing CS. Multiple formulations, extracts single bioactive phytochemicals without demonstrated strong anti-CS through mechanisms. evidence larger, well-designed trials their detailed action yet be well elucidated. More research warranted further evaluate value medicine COVID-19-induced

Language: Английский

Citations

3

Herb–drug interactions: Quantitative analysis of levofloxacin absorption and transporter expression in the rat intestine following combined treatment with Persicaria capitata (Buch.-Ham. ex D. Don) H. Gross DOI
Yang Zhou,

Mingyan Chi,

Zuying Zhou

et al.

Journal of Pharmaceutical and Biomedical Analysis, Journal Year: 2024, Volume and Issue: 245, P. 116156 - 116156

Published: April 16, 2024

Language: Английский

Citations

2

Activation of PXR causes drug interactions with Paxlovid in transgenic mice DOI Creative Commons
Saifei Lei,

Aaron j Guo,

Jie Lu

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2023, Volume and Issue: 13(11), P. 4502 - 4510

Published: Aug. 7, 2023

Paxlovid is a nirmatrelvir (NMV) and ritonavir (RTV) co-packaged medication used for the treatment of coronavirus disease 2019 (COVID-19). The active component NMV RTV pharmacokinetic booster. Our work aimed to investigate drug/herb-drug interactions associated with provide mechanism-based guidance clinical use Paxlovid. By using recombinant human cytochrome P450s (CYPs), we confirmed that CYP3A4 3A5 are major enzymes responsible metabolism. role CYP3A in metabolism were further verified Cyp3a-null mice, which showed deficiency significantly suppressed RTV. Pregnane X receptor (PXR) ligand-dependent transcription factor upregulates CYP3A4/5 expression. We next explored impact drug- herb-mediated PXR activation on transgenic mouse model expressing CYP3A4/5. found increased expression, accelerated metabolism, reduced systemic exposure NMV. In summary, our demonstrated can cause drug Paxlovid, suggesting PXR-activating drugs herbs should be cautiously COVID-19 patients receiving

Language: Английский

Citations

4

An Overview of Medical uses and Chemical Composition of Arctium tomentosum mill. DOI Open Access
Alibek Ydyrys

Engineered Science, Journal Year: 2023, Volume and Issue: unknown

Published: Jan. 1, 2023

The current research has revealed that Arctium tomentosum renowned pharmacological potentialities, including anti-inflammatory, anticancer, antioxidant, antimicrobial, and bioactive phytochemicals, phenolic compounds.

Language: Английский

Citations

4

A strategy takes “Yiqing” tablets as an example to carry out simpler multi-component quantification and use fingerprint technology for comprehensive quality consistency evaluation DOI
Xiaoling Liu, Ting Yang, Lu Chen

et al.

Journal of Pharmaceutical and Biomedical Analysis, Journal Year: 2023, Volume and Issue: 238, P. 115809 - 115809

Published: Nov. 3, 2023

Language: Английский

Citations

4

Zedoary turmeric oil injection ameliorates lung inflammation via platelet factor 4 and regulates gut microbiota disorder in respiratory syncytial virus-infected young mice DOI Creative Commons

Yu‐Zhuo Wu,

Qian Zhang, Hua Li

et al.

Chinese Medicine, Journal Year: 2024, Volume and Issue: 19(1)

Published: June 11, 2024

Abstract Background Respiratory syncytial virus (RSV)-induced lung inflammation is one of the main causes hospitalization and easily disruption intestinal homeostasis in infants, thereby resulting a negative impact on their development. However, current clinical drugs are not satisfactory. Zedoary turmeric oil injection (ZTOI), patented traditional Chinese medicine (TCM), has been used for management inflammatory diseases. its vivo efficacy against RSV-induced underlying mechanism remain unclear. Purpose The present study was designed to confirm ZTOI disorders RSV-infected young mice explore potential mechanism. Study design methods Lung induced by RSV, cytokine antibody arrays were clarify effectiveness RSV pneumonia. Subsequently, key therapeutic targets pneumonia identified through multi-factor detection further confirmed. material basis target tissues determined non-target mass spectrometry. After confirming that pharmacological substances can reach intestine, we 16S rRNA-sequencing technology effect bacteria. Results In mouse model, significantly reduced levels serum myeloperoxidase, amyloid A, C-reactive protein, thymic stromal lymphoprotein; inhibited mRNA expression IL-10 IL-6; decreased pathological changes lungs. Immunofluorescence qPCR experiments showed load According arrays, platelet factor 4 (PF4), weak chemotactic mainly synthesized megakaryocytes, concentration-dependent change affected ZTOI, which could be exert anti-inflammatory effects. Additionally, sesquiterpenes enriched lungs intestines, exerting regulatory effects gut microbiota. Conclusion protect from via PF4 regulate microbiota disorder sesquiterpenes, provides reference application

Language: Английский

Citations

1

Screening for anti-influenza virus compounds from traditional Mongolian medicine by GFP-based reporter virus DOI Creative Commons

Maoshun Nie,

Xiaohe Li, Sen Zhang

et al.

Frontiers in Cellular and Infection Microbiology, Journal Year: 2024, Volume and Issue: 14

Published: July 12, 2024

Introduction Screening for effective antiviral compounds from traditional Mongolian medicine not only aids in the research of mechanisms medicines, but is also significant importance development new drugs targeting influenza A virus. Our study aimed to establish high-throughput, rapid screening methods against virus abundant resources medicine. Methods The use GFP-based reporter viruses plays a pivotal role by enabling and precise identification that inhibit viral replication. Herein, was used identify potent anti-influenza within Results led discovery three active compounds: Cardamonin, Curcumin, Kaempferide, all which exhibited properties vitro . Subsequent analysis confirmed their effectiveness largely due stimulation signaling pathways host cells, rather than direct interference with components, such as polymerase. Discussion This showcased high-throughput unearth agents medicine, contains rich deserves further exploration. Despite certain limitations, fluorescent present substantial potential drug high throughput efficiency.

Language: Английский

Citations

1